Generation and functional characterization of mice with a disrupted glutathione S-transferase, theta 1 gene. 2007

Kazunori Fujimoto, and Shingo Arakawa, and Toshiyuki Watanabe, and Hiroaki Yasumo, and Yosuke Ando, and Wataru Takasaki, and Sunao Manabe, and Takashi Yamoto, and Sen-Ichi Oda
Medicinal Safety Research Laboratories, Daiichi Sankyo Co Ltd, Fukuroi, Shizuoka, Japan. fujimoto.kazunori.wr@daiichisankyo.co.jp

Glutathione S-transferase (GST) theta 1 (GSTT1) has been regarded as one of the key enzymes involved in phase II reactions because of its unique substrate specificity. In this study, we generated mice with the disrupted Gstt1 gene (Gstt1-null mice) by gene targeting and analyzed the metabolic properties in cytosolic and in vivo studies. The resulting Gstt1-null mice failed to express the Gstt1 mRNA and GSTT1 protein by reverse transcriptase-polymerase chain reaction analysis and two-dimensional fluorescence difference gel electrophoresis/mass spectrometry analysis, respectively. However, the Gstt1-null mice appeared to be normal and were fertile. In an enzymatic study using cytosolic samples from the liver and kidney, GST activity toward 1,2-epoxy-3-(p-nitrophenoxy)propane (EPNP), dichloromethane (DCM), and 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU) was markedly lower in Gstt1-null mice than in the wild-type controls, despite there being no difference in GST activity toward 1-choloro-2,4-dinitrobenzene between Gstt1-null mice and the wild-type controls. Gstt1-null mice had GST activity of only 8.7 to 42.1% of the wild-type controls to EPNP, less than 2.2% of the wild-type controls to DCM, and 13.2 to 23.9% of the wild-type controls to BCNU. Plasma BCNU concentrations after a single i.p. administration of BCNU to Gstt1-null mice were significantly higher, and there was a larger area under the curve(5-60) min (male, 2.30 times; female, 2.28 times, versus the wild-type controls) based on the results. In conclusion, Gstt1-null mice would be useful as an animal model of humans with the GSTT1-null genotype.

UI MeSH Term Description Entries
D007274 Injections, Intraperitoneal Forceful administration into the peritoneal cavity of liquid medication, nutrient, or other fluid through a hollow needle piercing the abdominal wall. Intraperitoneal Injections,Injection, Intraperitoneal,Intraperitoneal Injection
D007668 Kidney Body organ that filters blood for the secretion of URINE and that regulates ion concentrations. Kidneys
D007700 Kinetics The rate dynamics in chemical or physical systems.
D008099 Liver A large lobed glandular organ in the abdomen of vertebrates that is responsible for detoxification, metabolism, synthesis and storage of various substances. Livers
D008297 Male Males
D008752 Methylene Chloride A chlorinated hydrocarbon that has been used as an inhalation anesthetic and acts as a narcotic in high concentrations. Its primary use is as a solvent in manufacturing and food technology. Dichloromethane,Methylene Bichloride,Methylene Dichloride,Solaesthin,Bichloride, Methylene,Chloride, Methylene,Dichloride, Methylene
D008810 Mice, Inbred C57BL One of the first INBRED MOUSE STRAINS to be sequenced. This strain is commonly used as genetic background for transgenic mouse models. Refractory to many tumors, this strain is also preferred model for studying role of genetic variations in development of diseases. Mice, C57BL,Mouse, C57BL,Mouse, Inbred C57BL,C57BL Mice,C57BL Mice, Inbred,C57BL Mouse,C57BL Mouse, Inbred,Inbred C57BL Mice,Inbred C57BL Mouse
D009596 Nitrophenols PHENOLS carrying nitro group substituents. Nitrophenol
D010641 Phenotype The outward appearance of the individual. It is the product of interactions between genes, and between the GENOTYPE and the environment. Phenotypes
D002330 Carmustine A cell-cycle phase nonspecific alkylating antineoplastic agent. It is used in the treatment of brain tumors and various other malignant neoplasms. (From Martindale, The Extra Pharmacopoeia, 30th ed, p462) This substance may reasonably be anticipated to be a carcinogen according to the Fourth Annual Report on Carcinogens (NTP 85-002, 1985). (From Merck Index, 11th ed) BCNU,1,3-Bis(2-Chloroethyl)-1-Nitrosourea,BiCNU,FIVB,N,N'-Bis(2-Chloroethyl)-N-Nitrosourea,Nitrumon

Related Publications

Kazunori Fujimoto, and Shingo Arakawa, and Toshiyuki Watanabe, and Hiroaki Yasumo, and Yosuke Ando, and Wataru Takasaki, and Sunao Manabe, and Takashi Yamoto, and Sen-Ichi Oda
July 2001, European journal of biochemistry,
Kazunori Fujimoto, and Shingo Arakawa, and Toshiyuki Watanabe, and Hiroaki Yasumo, and Yosuke Ando, and Wataru Takasaki, and Sunao Manabe, and Takashi Yamoto, and Sen-Ichi Oda
June 2009, Leukemia & lymphoma,
Kazunori Fujimoto, and Shingo Arakawa, and Toshiyuki Watanabe, and Hiroaki Yasumo, and Yosuke Ando, and Wataru Takasaki, and Sunao Manabe, and Takashi Yamoto, and Sen-Ichi Oda
January 2021, International journal of applied & basic medical research,
Kazunori Fujimoto, and Shingo Arakawa, and Toshiyuki Watanabe, and Hiroaki Yasumo, and Yosuke Ando, and Wataru Takasaki, and Sunao Manabe, and Takashi Yamoto, and Sen-Ichi Oda
October 2012, Journal of ginseng research,
Kazunori Fujimoto, and Shingo Arakawa, and Toshiyuki Watanabe, and Hiroaki Yasumo, and Yosuke Ando, and Wataru Takasaki, and Sunao Manabe, and Takashi Yamoto, and Sen-Ichi Oda
September 1992, The Biochemical journal,
Kazunori Fujimoto, and Shingo Arakawa, and Toshiyuki Watanabe, and Hiroaki Yasumo, and Yosuke Ando, and Wataru Takasaki, and Sunao Manabe, and Takashi Yamoto, and Sen-Ichi Oda
May 2000, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology,
Kazunori Fujimoto, and Shingo Arakawa, and Toshiyuki Watanabe, and Hiroaki Yasumo, and Yosuke Ando, and Wataru Takasaki, and Sunao Manabe, and Takashi Yamoto, and Sen-Ichi Oda
April 2017, Fish & shellfish immunology,
Kazunori Fujimoto, and Shingo Arakawa, and Toshiyuki Watanabe, and Hiroaki Yasumo, and Yosuke Ando, and Wataru Takasaki, and Sunao Manabe, and Takashi Yamoto, and Sen-Ichi Oda
January 2019, The journal of obstetrics and gynaecology research,
Kazunori Fujimoto, and Shingo Arakawa, and Toshiyuki Watanabe, and Hiroaki Yasumo, and Yosuke Ando, and Wataru Takasaki, and Sunao Manabe, and Takashi Yamoto, and Sen-Ichi Oda
October 1997, International journal of hematology,
Kazunori Fujimoto, and Shingo Arakawa, and Toshiyuki Watanabe, and Hiroaki Yasumo, and Yosuke Ando, and Wataru Takasaki, and Sunao Manabe, and Takashi Yamoto, and Sen-Ichi Oda
May 1996, Biochemistry and molecular biology international,
Copied contents to your clipboard!